Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acquisition of Human Gynecologic Specimens to be Used in Studying the Causes, Diagnosis, Prevention and Treatment of Cancer

NCT00897442 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT00897442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00897442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acquisition of Human Gynecologic Specimens to be Used in Studying the Causes, Diagnosis, Prevention and Treatment of Cancer
Lead sponsor
Gynecologic Oncology Group
Phase
Observational
Overall status
Completed
Start date
June 30, 1992
Completion date
Not reported
Enrollment
275 (actual)
Sites
187

Conditions

As the registry lists them; a condition with its own page is linked.

borderline ovarian clear cell tumor, borderline ovarian serous tumor, cervical adenocarcinoma, cervical adenosquamous carcinoma, cervical small cell carcinoma, cervical squamous cell carcinoma, not otherwise specified, childhood embryonal rhabdomyosarcoma, childhood malignant ovarian germ cell tumor, endometrioid stromal sarcoma, gestational trophoblastic tumor, malignant mesothelioma, malignant ovarian epithelial tumor, melanoma, neoplasm of uncertain malignant potential, ovarian brenner tumor, ovarian clear cell cystadenocarcinoma, ovarian serous cystadenocarcinoma, paget disease of the vulva, recurrent cervical carcinoma, recurrent fallopian tube carcinoma, recurrent ovarian carcinoma, recurrent ovarian germ cell tumor, recurrent primary peritoneal carcinoma, recurrent uterine corpus carcinoma, recurrent vaginal carcinoma, recurrent vulvar carcinoma, stage i ovarian cancer, stage i uterine corpus cancer, stage i vaginal cancer, stage i vulvar cancer, stage ia cervical cancer, stage ia fallopian tube cancer, stage ia ovarian cancer, stage ia ovarian germ cell tumor, stage ib cervical cancer, stage ib fallopian tube cancer, stage ib ovarian cancer, stage ib ovarian germ cell tumor, stage ic fallopian tube cancer, stage ic ovarian cancer, stage ic ovarian germ cell tumor, stage ii ovarian cancer, stage ii uterine corpus cancer, stage ii vaginal cancer, stage ii vulvar cancer, stage iia cervical cancer, stage iia fallopian tube cancer, stage iia ovarian cancer, stage iia ovarian germ cell tumor, stage iib cervical cancer, stage iib fallopian tube cancer, stage iib ovarian cancer, stage iib ovarian germ cell tumor, stage iic fallopian tube cancer, stage iic ovarian cancer, stage iic ovarian germ cell tumor, stage iii borderline ovarian surface epithelial-stromal tumor, stage iii cervical cancer, stage iii uterine corpus cancer, stage iii vaginal cancer, stage iii vulvar cancer, stage iiia fallopian tube cancer, stage iiia ovarian cancer, stage iiia ovarian germ cell tumor, stage iiia primary peritoneal cancer, stage iiib fallopian tube cancer, stage iiib ovarian cancer, stage iiib ovarian germ cell tumor, stage iiib primary peritoneal cancer, stage iiic fallopian tube cancer, stage iiic ovarian cancer, stage iiic ovarian germ cell tumor, stage iiic primary peritoneal cancer, stage iv borderline ovarian surface epithelial-stromal tumor, stage iv fallopian tube cancer, stage iv ovarian cancer, stage iv primary peritoneal cancer, stage iv uterine corpus cancer, stage iva cervical cancer, stage iva vaginal cancer, stage ivb cervical cancer, stage ivb vaginal cancer, stage ivb vulvar cancer, uterine corpus cancer, uterine corpus leiomyosarcoma, vulvar squamous cell carcinoma